Sfoglia per Corso Innovation in immuno-mediated and hematological disorders
Refining measurable residual disease monitoring in Philadelphia positive acute lymphoblastic leukemia adult patients: new insights from methodological and molecular standpoints
2025
Role of Bone Marrow Stromal cells in the regulation of NKG2D and DNAM-1 ligand expression on Multiple Myeloma cells
2022
Role of donor clonal hematopoiesis-related mutations in recipients’ immunologic recovery after allogeneic stem cell transplantation
2026
The role of Notch signaling and epidermal cytokines in the Hailey-Hailey disease pathogenesis and in the DNA damage response
2021
Role of TP53 mutations and of MRD monitoring by IG/TR rearrangements in refining prognosis of KMT2A-rearranged adult B-lineage Acute Lymphoblastic Leukemia patients
2026
STAT3 activation hallmarks human atypical T-betpos B cells and reveals IL-21–driven proliferative potential
2026
Synovial macrophages in patients with reumatoid arthritis: predictors of response and their modifications to treatment
2025
Targeting RNA Polymerase I to boost Natural Killer cell anticancer activity in multiple myeloma
2026
Unraveling the mechanisms of B cell response in health and disease across different ages: lessons form the Sars-Cov-2 pandemic
2025
Unveiling mast cell plasticity in colorectal cancer
2025
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile